Lu Wang

Lu Wang is the Director of Analytical Development at Spruce Biosciences, where they oversee all activities related to late-stage CMC small molecule drug product development. They provided technical and project leadership throughout the commercialization process and managed CMO activities for product development. Previously, Lu held positions such as Director of CMC at NovaBay Pharmaceuticals and Head of CMC at Atom Therapeutics. With a Bachelor’s degree in Chemistry from Peking University and a PhD in Analytical Chemistry from Purdue University, Lu continues to contribute significantly to the field with their extensive experience in analytical development and quality control.